VIATRIS ASIA PACIFIC PTE LIMITED

VIATRIS ASIA PACIFIC PTE LIMITED, as part of the global Viatris organization, is primarily a manufacturer with extensive factory operations in India.

Viatris is a global healthcare company dedicated to empowering people worldwide to live healthier at every stage of life. The company was formed in 2020 through the combination of Mylan and Upjohn, a former division of Pfizer. In India, Viatris maintains a substantial footprint, which includes research and development centers, multiple advanced manufacturing facilities, and a strong commercial and distribution network. The company is a significant producer of high-quality generic, branded generic, and over-the-counter medicines, as well as biosimilars. Its Indian operations are crucial to its global supply chain, producing a wide array of active pharmaceutical ingredients and finished dosage forms across various therapeutic areas for both domestic and international markets.

Viatris in India offers a diverse portfolio of products, including:

* **Branded Generics:** A wide range of generic medicines marketed under brand names.

* **Complex Generics:** More difficult-to-manufacture generic drugs, such as injectables and transdermals.

* **Biosimilars:** Versions of biologic medicines that are similar to the original reference product.

* **OTC (Over-the-Counter) Products:** Medications available without a prescription.

* **Active Pharmaceutical Ingredients (APIs):** The raw materials used to manufacture drugs.

These products cover various therapeutic areas, including cardiovascular, anti-infectives, diabetes, pain management, and women's health.